Airbus and Boeing. Apple and Microsoft. Coca Cola and Pepsi. At his Seqonomics blog, Art Wuster points to these as examples of duopolies. He then asks: "How close the next-generation sequencing market … to being dominated by the Illumina and Life Technologies duopoly?"

While he notes Illumina has captured the largest share of the next-gen sequencing market to date, Life Tech is not so far behind — and other firms are beginning to come online.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Chan Zuckerberg Initiative is investing in Cold Spring Harbor Laboratory's BioRxiv.

A study appearing in PLOS One finds that shortened consent forms don't affect clinical trial participants' understanding of the study.

The National Security Agency monitored signal intelligence for signs of "nefarious" genetic engineering projects, Gizmodo reports.

In Nature this week: barley genome sequenced, method for genotyping and phasing short tandem repeats, and more.